Breaking News

NEW YORK, Jan 3 — One Genzyme business division has agreed to sell its cancer diagnostics intellectual property and licensing to another division, the company announced  on Th

LOS ANGELES, Jan. 3 - Don't call Protein Pathways a bioinformatics company. At least not anymore.

NEW YORK, Jan. 3 — Isis Pharmaceuticals' GeneTrove division has launched a functional genomics alliance with Amgen, Isis said on Thursday.

NEW YORK, Jan 2—Genome Therapeutics and Schering-Plough have extended their genomics-based research alliance for asthma drug discovery for an additional year, Genome Therapeutics said on Wednesday.

NEW YORK, Jan. 2 — Panacea Pharmaceuticals has added former US Food & Drug Administration commissioner Frank Young to its board of directors, the company said Wednesday.

Being the last TrendSpotter column of the year gives me the privilege of looking back on how our industry f

SAN FRANCISCO, Dec. 27 – The gray brick building that houses the Astrobiology and Life Sciences Laboratories looks out of place on the NASA Ames campus.


NEW YORK, Dec. 26 - Visible Genetics has secured $22 million in a private placement of some 2.6 million common shares, the company said on Wednesday. The funds will be used for general working capital purposes, Visible Genetics said.


NEW YORK, Dec. 21 - Applied Precision plans to release a new version of its DeltaVision restoration microscopy system early next year, a spokesman for the company has said.

NEW YORK, Dec. 21 - Deltagen said on Monday that a subscription to its DeltaBase technology expected to close before the end of the year will be delayed until the first quarter of 2002.



University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Futurism writes that gene doping could be the next generation of cheating in sports.